ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,401Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 93

$415K Total Retail Price of All Prescriptions

Rank: 14 out of 93

369 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 369 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

12% of this provider’s 369 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 8,468 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LISINOPRIL 434 287 1 3
LEVOTHYROXINE SODIUM 379 321 2 5
SIMVASTATIN 369 305 3 2
FUROSEMIDE 344 307 4 4
RANITIDINE HCL 305 194 5 21
METOPROLOL SUCCINATE 289 249 6 14
OMEPRAZOLE 288 238 7 8
POTASSIUM CHLORIDE 272 234 8 13
TRAMADOL HCL 259 146 9 15
METFORMIN HCL 257 195 10 7
MELOXICAM 248 183 11 42
METOPROLOL TARTRATE 247 191 12 11
HYDROCHLOROTHIAZIDE 239 175 13 10
AMLODIPINE BESYLATE 231 220 14 6
GABAPENTIN 203 137 15 17
HYDROCODONE-ACETAMINOPHEN 187 90 S3 16 9
CITALOPRAM HBR 182 122 17 45
GLYBURIDE 181 145 R 18 47
FELODIPINE ER 166 143 19 107
TAMSULOSIN HCL 162 150 20 24
PAROXETINE HCL 146 132 21 64
WARFARIN SODIUM 145 109 22 12
KLOR-CON 8 133 106 23 101
ENALAPRIL MALEATE 130 129 24 22
ATENOLOL 130 126 24 16
LOSARTAN POTASSIUM 122 91 26 26
CLONIDINE HCL 108 93 27 50
AMITRIPTYLINE HCL 105 65 R 28 61
SERTRALINE HCL 102 52 29 43
CYMBALTA 96 38 30 84
DONEPEZIL HCL 95 95 31 25
PRAVASTATIN SODIUM 93 72 32 20
BUPROPION HCL SR 91 49 33 190
ROPINIROLE HCL 91 65 33 120
ALLOPURINOL 85 66 35 29
TRIAMTERENE-HCTZ 79 58 36 29
KLOR-CON 10 78 53 37 66
PREDNISONE 75 64 38 49
CYCLOBENZAPRINE HCL 75 20 R 38 71
FLUDROCORTISONE ACETATE 72 60 40 212
AZITHROMYCIN 71 50 41 51
PROAIR HFA 70 43 42 37
CRESTOR 67 54 43 31
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 46 44 97
DIGOXIN 64 64 45 48
SPIRIVA 63 36 46 69
OXYBUTYNIN CHLORIDE 63 53 46 95
FLUOXETINE HCL 61 32 48 82
ALENDRONATE SODIUM 61 57 48 39
CLOPIDOGREL 58 47 50 27
CHOLESTYRAMINE 58 35 50 231
DOXYCYCLINE HYCLATE 56 28 52 114
VENLAFAXINE HCL ER 54 18 53 236
CARBIDOPA-LEVODOPA 52 52 54 113
DICLOFENAC SODIUM 50 46 55 170
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.